$8.48
-0.24 (-2.75%)
Open$8.65
Previous Close$8.72
Day High$8.69
Day Low$8.45
52W High$12.23
52W Low$2.59
Volume—
Avg Volume312.0K
Market Cap199.48M
P/E Ratio—
EPS$-0.81
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+500.5% upside
Current
$8.48
$8.48
Target
$50.92
$50.92
$37.48
$50.92 avg
$70.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 72.05M | 63.49M | 17.09M |
| Net Income | -21,590,047 | -17,122,878 | -4,142,594 |
| Profit Margin | -30.0% | -28.5% | -24.3% |
| EBITDA | -13,254,058 | -11,095,660 | -7,262,848 |
| Free Cash Flow | — | — | -5,494,601 |
| Rev Growth | +13.5% | +13.5% | +9.1% |
| Debt/Equity | 1.49 | 1.49 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |